作为心血管药理学中的目标,腺素信号传递
Luca Antonioli1, Matteo Fornai2, Carolina Pellegrini2
1Department of Clinical and Experimental Medicine, University of Pisa, 56126, Pisa, Italy.
Current opinion in pharmacology
|July 14, 2023
概括
腺系统在诸如高血压和心力衰竭等心血管疾病中起着关键作用. 研究正在探索腺受体 (A1,A2A,A2B,A3) 和潜在治疗方法的配体.
科学领域:
- 心血管研究研究心血管研究
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 腺系统越来越多地被认为与心血管疾病有关.
- 诸如高血压,心肌梗塞,缺血,心力衰竭和动脉样硬化等疾病与腺信号传递有关.
- 氨酸通过四个主要的膜受体发挥作用:A1,A2A,A2B和A3.
研究的目的:
- 为了提供一个全面的概述腺在心血管病理生理学中的作用.
- 综合当前临床和临床前证据关于腺对心脏病的影响.
- 为了突出药理联体,以治疗潜力向腺素通路.
主要方法:
- 临床和临床前研究的文献综述.
- 对腺受体 (A1,A2A,A2B,A3) 和它们的功能研究的分析.
- 针对腺系统的药理学药剂的评估.
主要成果:
- 腺素信号传递是各种心血管疾病的发展和进展的关键因素.
- 特定的腺受体 (A1,A2A,A2B,A3) 涉及到不同的病理生理过程.
- 腺路径的药理学调制显示出对控制心血管疾病的前景.
结论:
- 腺系统是心血管疾病的重要治疗点.
- 了解腺受体药理学对于开发新疗法至关重要.
- 对腺连接物的进一步研究可能会导致有效的心血管疾病管理策略.
相关概念视频
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
Adrenergic Receptors: ɑ Subtype
1.6K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.6K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
465
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
465
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
777
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
777
Antianginal Drugs: Nitrates and β-Blockers
652
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
652
Antihypertensive Drugs: Action of Calcium Channel Blockers
579
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
579


